Researchers see benefits, little risk from renal denervation

10/29/2012 | MedPage Today

The use of renal nerve ablation to treat refractory high blood pressure appears to carry long-term benefits with little risk of adverse events, according to researchers from Australia's Baker Heart and Diabetes Institute in Melbourne who reported the findings at TCT 2012. Within a month, 69% of patients demonstrated a response to the treatment, and at the three-year mark, 94% of remaining study participants had responded.

View Full Article in:

MedPage Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA